Psychedelic Drugs Market 2020-2027 Sets the Table for Continued Growth | Global Players - COMPASS, The Emmes Company, LLC, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd
Global psychedelic drugs market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Growing prevalence of depression worldwide and increase in special designation from the regulatory authorities to the company to expedite the development process are the key factors for market growth. Few of the major competitors currently working in the global psychedelic drugs market are COMPASS, The Emmes Company, LLC, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V., Merck & Co., Inc, Alkermes, ALLERGAN, H. Lundbeck A/S among others.
Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-psychedelic-drugs-market&pm
Market Definition: Global Psychedelic Drugs Market
Psychedelic drugs are also known as psychedelics are the class of hallucinogenic drugs including both classic hallucinogens as well as dissociative drugs that are used recreationally, to alter and enhance the sensory perception, elevate the mood swings, thought process, energy level promoting spiritual experiences. Psychedelic drugs have been used experimentally for psychological treatment and are able to control mind hence maintaining peace.
According to the statistic published in our World in Data 2017, the global burden of mental and substance use disorders were 122.76 million. Increase cases of mental disorders and accelerating demand of novel therapies are the drivers promoting the growth of this market.
Psychedelic drugs are the category of therapeutic pharmaceuticals that are responsible for instigating psychedelic expressions in the patient consuming these drugs with the help of serotonin receptor agonism. This subsequently results in a number of changes in the visual and auditory functions of the consumer. This alteration of bodily function is also combined with changes in the consciousness causing a change of mindset amongst the patients. A majority of the drugs produced for these functioning include being developed from LSD, ecstasy, ketamine amongst various others.
Psychedelic drugs market is growing due to increase in prevalence of depression worldwide, increase special designation from the regulatory authority; the effects of these factors are mentioned below:
Increase in prevalence of depression worldwide: Psychedelic drugs are used for the treatment of different variants of depression and other clinical indications, although the major focus is on the treatment of depression and other different types of mental disorders. This is due to their capability of invoking consciousness changes by altering the visual and auditory functioning of the consumers. Therefore, the growing volume of depression in patients is directly affecting the market’s potential for growth.
Increase special designation from the regulatory authority: Another important factor behind the market’s high growth potential is the different regional authorities providing specialized designation to these drug categories helping streamline the approval process by providing the specific requirements required from the drug for its approval in a timelier manner.
Product approvals along with establishing specialized research centers:
In September 2019, The Johns Hopkins University announced the launch of “Center for Psychedelic and Consciousness Research”, with the center responsible for testing the efficacy and effectiveness of using psychedelic compounds of different variants for the treatment of mental health problems. The center is the first established throughout the United States and was funded through approximately USD 17 million in donations. The center will also provide information and knowledge for students training them in the field of psychedelic science.
In March 2019, U.S. FDA announced that they had approved “Spravato (esketamine)” nasal spray in combination with oral antidepressant helping rectify depression in adults that have not been treated with other therapeutic methods. Although, the nasal spray would be available through restricted distribution system while being under a “Risk Evaluation and Mitigation Strategy (REMS)”. The drug developed by Janssen Pharmaceuticals, Inc is the first U.S. FDA approval of esketamine for any indication.
The market is segmented on the basis of application as major depressive disorder, resistant depression, panic disorder, post-traumatic stress disorder, opiate addiction and others. Drugs have been segmented into LSD, ecstasy, phencyclidine, GHB, ketamine, ayahuasca, salvia, psilocybin and others. Route of administration has been segmented as oral, injectable and inhalation. Distribution channel has been categorized as direct retailers, online pharmacies and others. End-users have been segmented as hospitals, homecare, specialty clinics and others.
“According to Data Bridge Market Research, Global Psychedelic Drugs Market is expected to be growing with a healthy CAGR during the forecast period of 2019 to 2026”
Some of the major players operating in market are COMPASS, The Emmes Company, LLC, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V., Merck & Co., Inc, Alkermes, ALLERGAN, H. Lundbeck A/S among others.
Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-psychedelic-drugs-market&pm
With the focus of authorities to work alongside specialized research organizations and pharmaceutical manufacturers to reduce the time required for the development and commercialization of psychedelic drugs for the treatment of different indications. These partnerships between different authorities and market players are resulting in quicker drug developments, product approvals and subsequent commercialization helping solve a clinically unmet need of different patients.
Global Psychedelic Drugs Market By Application (Major Depressive Disorder, Resistant Depression, Panic Disorder, Post-traumatic Stress Disorder, Opiate Addiction and Others), Drugs (Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, Phencyclidine, Gamma Hydroxybutyric Acid, Ketamine, Ayahuasca, Salvia, Psilocybin and Others), Route of Administration (Oral, Injectable and Inhalation), Distribution Channel (Direct Retailers, Online Pharmacies and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026
Increase in the prevalence of depression worldwide can act as a driver for the growth of this market
Treatment for psychedelic drugs dependency can also boost the market growth
Changing life style and requirement for enhanced and better life quality is propelling the market growth
Increase special designation from the regulatory authority can drive the market growth
Hefty and stringent regulation imposed by the government to commercialize psychedelic drugs are hindering the market growth
High preference of non-therapeutics therapies over pharmacological therapies can also hinder the market growth
Poor efficacy and safety profile of existing intervention also restricts the growth of the market
Segmentation: Global Psychedelic Drugs Market
Major Depressive Disorder
Post-traumatic stress disorder
Lysergic Acid Diethylamide (LSD)
Gamma Hydroxybutyric Acid (GHB)
By Route of Administration
By Distribution Channel
For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-psychedelic-drugs-market&pm
Key Developments in the Market:
In October 2018, COMPASS received Breakthrough Therapy designation from the FDA for psilocybin therapy for the treatment of resistant depression. With Breakthrough Therapy designation, company can obtain all fast track designation features and FDA commitment and guidance ensuring efficient drug development programme
In August 2018, COMPASS received new drug application approval from the FDA for the psilocybin therapy for the treatment of resistant depression. If the trial is successful, it will change the treatment landscape of patients suffering from resistant depression
Global psychedelic drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global psychedelic drugs market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global psychedelic drugs market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psychedelic Drugs Market 2020-2027 Sets the Table for Continued Growth | Global Players - COMPASS, The Emmes Company, LLC, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd here
News-ID: 2108801 • Views: 319
More Releases from Data Bridge Market Research
Dental Radiology Equipment Market 2020 Segment Analysis By VATECH, Midmark Corpo …
Dental Radiology Equipment Market is expected to rise from its initial estimated value of USD 2.68 billion in 2018 to an estimated value of USD 5.86 billion by 2026, registering a CAGR of 10.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the global increase in diagnostics creating huge scope. Few of the major competitors currently working in the dental radiology equipment market are Danaher
Dental Prosthetics Market Future Scope By Zimmer Biomet, Danaher, Henry Schein, …
Dental Prosthetics Market report makes sure to include every opportunity, challenges, drivers, market structures, and competitive scene for the customers. Two of the major tools of market analysis used here are SWOT analysis and Porter’s Five Forces Analysis. In addition, it combines comprehensive market analysis with specific estimates and predictions to give total research solution, most prominent clearness for key basic choices. The report exhibits significant item advancements and tracks ongoing
Dental Infection Control Market Top Players Analysis: Henry Schein, Inc., GC Ame …
Dental Infection Control Market By Product (Consumables, Equipment), End User (Dental Hospitals, Dental Clinics, Dental Research Institutes and Academics, Dental Laboratories), Geography (North America, Europe, South America, Asia-Pacific, Middle-East) – Industry Trends & Forecast to 2026 Some of the major players operating in this market are 3M, Young Innovations, Inc., Kerr Corporation, Henry Schein, Inc., GC America Inc., A-dec Inc., Dentsply Sirona, COLTENE Group, Kol Al-Hamaya Factory, Medicom, Schulke & Mayr UK
Deep Brain Stimulation Systems Market Growth to 2027: Leading Players are NeuroP …
The global deep brain stimulation systems market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.5% in the forecast period of 2020 to 2027 and expected to reach USD 1,954.35 million by 2027 from USD 1,017.57 million in 2019. Rising demand for early and accurate disease diagnosis is the factor
More Releases for Psychedelic
Psychedelic Drugs Market Size By Doughlas pharmaceuticals limited, NeuroRX, Inc. …
The winning Psychedelic Drugs Market report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast moving business environment. What is more, get details about historic data, present market trends, future product environment, marketing strategies, technological innovation, upcoming technologies, emerging trends or opportunities, and the technical progress in the related industry in this Psychedelic Drugs Market research report. The business report is
Psychedelic Drugs Market Report Explored In Latest Research 2020 – 2026 | Emer …
A world-wide Psychedelic Drugs Market research report offers an array of insights about Healthcare industry and business solutions that will support to stay ahead of the competition. Businesses are highly relying on different segments covered in the market research report which gives better insights to drive their business into right direction. This market report is built by chewing over several fragments of the present and upcoming market scenario because an
Psychedelic Drugs Market (COVID-19 Impact Analysis) 2020 Global Industry Outlook …
Psychedelic Drugs market research report indicates that the global market is predictable to surge at a steady rate in the coming years. Market analysts have identified the key drivers and restraints in the overall market. The historical milestones achieved by the global market and emerging trends have also been studied in this Psychedelic Drugs market report. The report makes available comprehensive review of the global market. Adopting such market research
Psychedelic Drugs Market Growth Powered with Latest Development Scenario & Influ …
DBMR announces the release of the report “Psychedelic Drugs Market” Size, Share & Trends Analysis Report By 2027. Psychedelic Drugs Market is 2020 Research Report on Global professional and comprehensive report on the Psychedelic Drugs Market. The report monitors the key trends and market drivers in the current scenario and offers on the ground insights. This report highlights key market dynamics of Psychedelic Drugs industry and covers historic data, present market trends,
Psychedelic Drugs Market to Show Tremendous Growth by 2027 | Leading Players-COM …
Global Psychedelic Drugs Market research report involves a key data and information about the market, emerging trends, product usage, motivating factors for customers and competitors, restraints, brand positioning, and customer behaviour, which is of utmost importance when it comes to achieving a success in the competitive marketplace. Thus, the report deals with plentiful aspects of the industry. This market report provides with CAGR value fluctuation during the forecast period of
Psychedelic Drugs Market in North America Shows Unbelievable Growth in 2020 | CO …
A market research report such as this Psychedelic Drugs Market in North America report is absolutely essential in today's highly competitive world, wherein businesses need to collect data and information to tap emerging opportunities and to position themselves outstandingly in the market. A good market research report has information on almost everything : be it about prospective clients, segmentation of market or growth opportunities. Therefore, DBMR team has generated this